26 September 2013


Michael Deats, Project Manager, Quality Assurance and Safety: Medicines, World Health Organization (WHO) 
Andrew Jackson, Head, Global Corporate Security, NOVARTIS
Dr Mohga Kamal-Yanni, Senior Health & HIV Policy Advisor, Oxfam
Professor Martin McKee CBE, Professor of European Public Health, London School of Hygiene & Tropical Medicine


Counterfeit, falsified and substandard medicines are a global phenomenon which poses a continued threat to health security. Producing fake medicines is big business, bolstered by the rise of internet sales of pharmaceuticals, and health workers are warning of a mounting crisis, particularly in poor countries. 

The panel consider the scale of the problem worldwide, and discuss how to encourage a successful, global approach to combating fake medicines. They comment upon the response of the pharmaceutical industry, the differing needs of developing and developed nations, and how the drivers of the problem can be tackled effectively.